Navigation Links
Pulmonary Fibrosis Contributes to Beloved Civil Rights Writer and Folk Singer Odetta's Death
Date:12/4/2008

SAN JOSE, Calif., Dec. 4 /PRNewswire-USNewswire/ -- Music and civil rights icon Odetta succumbed December 2 as a result of multiple illnesses. One of them was pulmonary fibrosis (PF), an illness that relentlessly fills the lungs with scar tissue and suffocates its victims, and is one of the deadliest yet least well known diseases in the country. Despite being diagnosed with PF two years ago, a diagnosis that was essentially a death sentence, Odetta went on to perform extraordinary concerts all over the world. Her doctors were amazed at her determination to sing while battling the disease. Despite her markedly reduced lung capacity, she managed to complete entire concerts and only access her supplemental oxygen as she left the stage.

Pulmonary Fibrosis (PF) is a tissue debilitating lung disease that causes progressive scarring of the lungs, ultimately robbing a person of the ability to breathe. As many people die each year to PF as to breast cancer, yet most have never heard of it until they receive the devastating diagnosis. More than 128,000 suffer from the disease and incidence and prevalence has increased more than 150 percent in the last several years.

"We are deeply saddened at the loss of such a beloved singer and civil rights legend," said Mishka Michon, chief executive officer for the Coalition for Pulmonary Fibrosis (CPF). "We lose 40,000 people a year to this disease (as many as are lost to breast cancer), and each loss is painful. Odetta's death highlights for the nation, and for her fans, what those of us fighting pulmonary fibrosis already know - that there is a killer disease randomly striking thousands and we have no treatments. Marlon Brando, Gordon Jump and Robert Goulet's lives were among those cut down by pulmonary fibrosis - we don't want to see these losses continue at their current pace. We can only hope that, with increased awareness and funding for research, the future will change for others."

Odetta's manager, Doug Yeager, told the CPF she was diagnosed with PF two years ago but refused to let the grim prognosis get her down. Most patients live less than three years and few are able to continue a normal life because of the extremely life limiting breathlessness and related exhaustion.

Odetta used supplemental oxygen for the two years she suffered, but somehow had the strength to perform more than 60 concerts after her diagnosis around the world - all of her performances except for one were completed without her having to use an oxygen tank, Yeager said.

"She wouldn't use her oxygen during her concerts. Somehow, she'd go out and sing for 90 minutes without it," Yeager said. The only concert she performed with supplemental oxygen was one in Denver, Colorado, a city that sits at 5,280 feet of elevation, he said.

There is no FDA approved treatment for PF, no known cause and no cure. Odetta is one of 40,000 people who will die this year from the disease. The CPF has counseled thousands of patients and family members who've faced pulmonary fibrosis. To learn more, please visit: www.coalitionforpf.org.

Odetta's last concert performance was October 26th of this year, according to Yeager. She also performed a concert October 6th, in front of 100,000 people at San Francisco's Golden Gate Park.

About Pulmonary Fibrosis (PF)

PF is a lung disorder characterized by a progressive scarring - known as fibrosis - and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from IPF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. IPF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes pulmonary fibrosis can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure pulmonary fibrosis; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 16,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with pulmonary fibrosis. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information
2. Pulmonary Hypertension Treated with Stem Cells : International Medical Team Announces Patient Results in Adult Stem Cell Clinical Study for Pulmonary Hypertension
3. Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act Increases to 27 Members
4. Viagra Bulk Effectively Cures Children with PAH (Pulmonary Arterial Hypertension)
5. Women at Higher Risk for Pulmonary Hypertension
6. Cialis May Help Ease Pulmonary Hypertension
7. Tomophase to Exhibit First In-vivo Cross-sectional Images of Pulmonary Stenting Using Proprietary OCT System
8. Eisai Inc. Supports Acting Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
9. The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
10. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
11. American Lung Association Commends U.S. House of Representatives for Passage of Pulmonary and Cardiac Rehabilitation Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology: